Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer Biology & Medicine|May 22, 2013
Histone deacetylase inhibition: an important mechanism in the treatment of lymphomaShan-Qi Guo, Yi-Zhuo ZhangChinese Medical Journal|October 19, 2012
Overexpression of enhancer of zests homolog 2 in lymphomaShan-Qi Guo, Yi-Zhuo ZhangZhongguo Shi Yan Xue Ye Xue Za Zhi|June 29, 2012
[Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome]Ya-Qin Zhi, Shan-Qi Guo, Yi-Zhuo ZhangZhonghua Yi Xue Za Zhi|October 16, 2013
[Role of c-Myc in mesenchymal stromal cell-mediated drug resistance in acute leukemia cells]Bing Xia, Qing Guo, Wei-peng Zhao, et al.Translational Andrology and Urology|September 16, 2024
Management considerations and treatment outcomes for newly diagnosed prostate cancer in advanced age patients (≥80 years): real-world data from a single urological center over a 10-year periodXiong Xiao, Jun-Xin Wang, Yong Wang, et al.Translational Andrology and Urology|December 19, 2024
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤60 years: real-world data from a single urological center over a 10-year periodWei Liu, Shan-Qi Guo, Xiong Xiao, et al.Oncotargets and Therapy|November 22, 2013
Prognostic factors associated with solitary plasmacytomaShan-Qi Guo, Le Zhang, Ya-Fei Wang, et al.World Journal of Gastroenterology|March 6, 2015
Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphomaBing Xia, Le Zhang, Shan-Qi Guo, et al.Pageof 1